Live from the NIH registry
Studies recruiting near Topeka right now
Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Topeka, Kansas (1.3 mi)
· Sponsor: GlaxoSmithKline
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Overweight, Obesity
Phase 2
Interventional 400 participants sought
Cotton O'Neil Diabetes & Endocrinology — Topeka, Kansas (1.3 mi)
· Sponsor: Eli Lilly and Company
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Topeka, Kansas (1.3 mi)
· Sponsor: Hoffmann-La Roche
Optimizing a Sensor-Enabled mHealth Intervention for Adolescents With Suboptimal Asthma Control
Asthma (Diagnosis)
N/A
Interventional 160 participants sought
University of Kanas — Lawrence, Kansas (25.1 mi)
· Sponsor: University of Kansas
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Cotton O'Neil Digestive Health Center — Topeka, Kansas (1.3 mi)
· Sponsor: Eli Lilly and Company
Measuring Surgical Recovery After Radical Cystectomy
Bladder Cancer
N/A
Observational 2,000 participants sought
University of Kansas Medical Center — Lawrence, Kansas (25.1 mi)
· Sponsor: M.D. Anderson Cancer Center
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8
Phase 1, Phase 2
Interventional 92 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi)
· Sponsor: SWOG Cancer Research Network
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 147 participants sought
Cotton O'Neil Cancer Center / Stormont Vail Health — Topeka, Kansas (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 3
Interventional 1,978 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Myasthenia Gravis
Phase 2, Phase 3
Interventional 12 participants sought
University of Kansas Medical Center — Lawrence, Kansas (25.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Phase 3
Interventional 1,200 participants sought
Cotton O'Neil Digestive Health Center ( Site 5033) — Topeka, Kansas (1.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Kansas Medical Clinic PA — Topeka, Kansas (1.3 mi)
· Sponsor: Boehringer Ingelheim
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
Lawrence Memorial Hospital — Lawrence, Kansas (25.1 mi)
· Sponsor: National Cancer Institute LAO
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
University of Kansas Health System Saint Francis Campus — Topeka, Kansas (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Topeka, Kansas (1.3 mi)
· Sponsor: Akero Therapeutics, Inc
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 10,450 participants sought
Cotton O'Neil Clinical Research Center — Topeka, Kansas (1.3 mi)
· Sponsor: Eli Lilly and Company